Logo image of SANG

SANGOMA TECHNOLOGIES CORP (SANG) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SANG - CA80100R4089 - Common Stock

4.96 USD
-0.07 (-1.39%)
Last: 12/29/2025, 8:18:43 PM
Fundamental Rating

3

Overall SANG gets a fundamental rating of 3 out of 10. We evaluated SANG against 48 industry peers in the Communications Equipment industry. Both the profitability and financial health of SANG have multiple concerns. SANG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SANG has reported negative net income.
SANG had a positive operating cash flow in the past year.
In the past 5 years SANG reported 4 times negative net income.
Each year in the past 5 years SANG had a positive operating cash flow.
SANG Yearly Net Income VS EBIT VS OCF VS FCFSANG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

SANG's Return On Assets of -1.61% is in line compared to the rest of the industry. SANG outperforms 50.00% of its industry peers.
Looking at the Return On Equity, with a value of -2.16%, SANG is in line with its industry, outperforming 52.08% of the companies in the same industry.
Industry RankSector Rank
ROA -1.61%
ROE -2.16%
ROIC N/A
ROA(3y)-3.39%
ROA(5y)-6.47%
ROE(3y)-5.4%
ROE(5y)-10.77%
ROIC(3y)N/A
ROIC(5y)N/A
SANG Yearly ROA, ROE, ROICSANG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

SANG has a better Gross Margin (69.22%) than 91.67% of its industry peers.
In the last couple of years the Gross Margin of SANG has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SANG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y1.11%
SANG Yearly Profit, Operating, Gross MarginsSANG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

SANG does not have a ROIC to compare to the WACC, probably because it is not profitable.
SANG has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SANG has more shares outstanding
The debt/assets ratio for SANG has been reduced compared to a year ago.
SANG Yearly Shares OutstandingSANG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
SANG Yearly Total Debt VS Total AssetsSANG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 1.17, we must say that SANG is in the distress zone and has some risk of bankruptcy.
SANG's Altman-Z score of 1.17 is in line compared to the rest of the industry. SANG outperforms 47.92% of its industry peers.
SANG has a debt to FCF ratio of 1.93. This is a very positive value and a sign of high solvency as it would only need 1.93 years to pay back of all of its debts.
SANG has a better Debt to FCF ratio (1.93) than 66.67% of its industry peers.
SANG has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
SANG has a Debt to Equity ratio (0.11) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.93
Altman-Z 1.17
ROIC/WACCN/A
WACC8.66%
SANG Yearly LT Debt VS Equity VS FCFSANG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.87 indicates that SANG may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.87, SANG is doing worse than 95.83% of the companies in the same industry.
A Quick Ratio of 0.72 indicates that SANG may have some problems paying its short term obligations.
The Quick ratio of SANG (0.72) is worse than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.72
SANG Yearly Current Assets VS Current LiabilitesSANG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

3

3. Growth

3.1 Past

SANG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.00%, which is quite impressive.
Looking at the last year, SANG shows a decrease in Revenue. The Revenue has decreased by -6.97% in the last year.
The Revenue has been growing by 19.31% on average over the past years. This is quite good.
EPS 1Y (TTM)36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y1.79%
Revenue growth 5Y19.31%
Sales Q2Q%-15.51%

3.2 Future

Based on estimates for the next years, SANG will show a very strong growth in Earnings Per Share. The EPS will grow by 53.23% on average per year.
SANG is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.32% yearly.
EPS Next Y-23.44%
EPS Next 2Y53.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.47%
Revenue Next 2Y-4.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SANG Yearly Revenue VS EstimatesSANG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
SANG Yearly EPS VS EstimatesSANG Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

3

4. Valuation

4.1 Price/Earnings Ratio

SANG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 95.04 indicates a quite expensive valuation of SANG.
Based on the Price/Forward Earnings ratio, SANG is valued a bit more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SANG to the average of the S&P500 Index (23.40), we can say SANG is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 95.04
SANG Price Earnings VS Forward Price EarningsSANG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SANG is valued cheaper than 97.92% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SANG indicates a rather cheap valuation: SANG is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.28
EV/EBITDA 4.68
SANG Per share dataSANG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

SANG's earnings are expected to grow with 53.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SANG!.
Industry RankSector Rank
Dividend Yield 0%

SANGOMA TECHNOLOGIES CORP

NASDAQ:SANG (12/29/2025, 8:18:43 PM)

4.96

-0.07 (-1.39%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)02-03 2026-02-03
Inst Owners34.91%
Inst Owner Change-7.36%
Ins Owners27.21%
Ins Owner ChangeN/A
Market Cap164.37M
Revenue(TTM)227.36M
Net Income(TTM)-5.44M
Analysts82
Price Target8.41 (69.56%)
Short Float %0.1%
Short Ratio5.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)285.64%
Min EPS beat(2)-23.76%
Max EPS beat(2)595.05%
EPS beat(4)1
Avg EPS beat(4)85.56%
Min EPS beat(4)-197.03%
Max EPS beat(4)595.05%
EPS beat(8)2
Avg EPS beat(8)30.1%
EPS beat(12)4
Avg EPS beat(12)5.37%
EPS beat(16)6
Avg EPS beat(16)-259.19%
Revenue beat(2)1
Avg Revenue beat(2)-0.06%
Min Revenue beat(2)-0.46%
Max Revenue beat(2)0.34%
Revenue beat(4)1
Avg Revenue beat(4)-2.55%
Min Revenue beat(4)-7.66%
Max Revenue beat(4)0.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.95%
Revenue beat(12)3
Avg Revenue beat(12)-2.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.19%
PT rev (1m)8.2%
PT rev (3m)1.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-46.67%
EPS NY rev (1m)-52.77%
EPS NY rev (3m)-587.4%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)-13.56%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)-14.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 95.04
P/S 0.72
P/FCF 6.28
P/OCF 4.75
P/B 0.65
P/tB N/A
EV/EBITDA 4.68
EPS(TTM)-0.16
EYN/A
EPS(NY)0.05
Fwd EY1.05%
FCF(TTM)0.79
FCFY15.92%
OCF(TTM)1.04
OCFY21.05%
SpS6.86
BVpS7.59
TBVpS-0.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.61%
ROE -2.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.22%
FCFM 11.51%
ROA(3y)-3.39%
ROA(5y)-6.47%
ROE(3y)-5.4%
ROE(5y)-10.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y1.11%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.93
Debt/EBITDA 0.67
Cap/Depr 18.9%
Cap/Sales 3.71%
Interest Coverage N/A
Cash Conversion 81.28%
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.72
Altman-Z 1.17
F-Score5
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)22.92%
Cap/Depr(5y)19.53%
Cap/Sales(3y)4.2%
Cap/Sales(5y)3.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y-23.44%
EPS Next 2Y53.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y1.79%
Revenue growth 5Y19.31%
Sales Q2Q%-15.51%
Revenue Next Year-12.47%
Revenue Next 2Y-4.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-112.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2299.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.51%
FCF growth 3Y27.36%
FCF growth 5Y36.51%
OCF growth 1Y12.7%
OCF growth 3Y25.66%
OCF growth 5Y36.31%

SANGOMA TECHNOLOGIES CORP / SANG FAQ

What is the fundamental rating for SANG stock?

ChartMill assigns a fundamental rating of 3 / 10 to SANG.


Can you provide the valuation status for SANGOMA TECHNOLOGIES CORP?

ChartMill assigns a valuation rating of 3 / 10 to SANGOMA TECHNOLOGIES CORP (SANG). This can be considered as Overvalued.


What is the profitability of SANG stock?

SANGOMA TECHNOLOGIES CORP (SANG) has a profitability rating of 3 / 10.


Can you provide the financial health for SANG stock?

The financial health rating of SANGOMA TECHNOLOGIES CORP (SANG) is 3 / 10.